期刊文献+

无血清悬浮培养CHO-K1-SFS细胞系的建立及其生物学特性 被引量:2

Establishment and biological characteristics of serum-free suspension culture of CHO-K1-SFS cell line
原文传递
导出
摘要 目的建立无血清悬浮培养CHO-K1-SFS细胞系,并检测其生物学特性。方法将CHO-K1贴壁细胞通过逐步降低血清浓度,获得低血清CHO-K1贴壁细胞,以3×105个/ml接种于含无血清培养基SFM4CHO的150 ml三角瓶中,摇床无血清适应培养,获得CHO-K1-SFS细胞。对该细胞进行生长曲线绘制、微生物污染检测、代谢分析及外源基因表达检测。结果所获得的CHO-K1-SFS细胞系可无血清悬浮培养,以3×105个/ml的初始密度接种,最大增殖浓度可达3.8×106个/ml,平均倍增时间为29.7 h;无细菌、真菌、病毒和支原体污染;对葡萄糖利用率较高,乳酸产生较多;能较好地表达外源基因。结论成功建立了无血清悬浮培养CHO-K1-SFS细胞系,为建立高效的外源基因表达平台奠定了基础。 Objective To establish the serum-free suspension culture of CHO-K1-SFS cell line and determine its biological characteristics. Methods Adherent CHO-K1 cells were cultured by gradually decreasing serum concentration,and the obtained CHO-K1 cells in low serum medium were inoculated at a density of 3 × 10^5cells / ml to 150 ml Erlenmeyer flask containing serum-free SFM4CHO medium and cultured in shaker. The growth curve of the obtained CHO-K1-SFS cells was plotted,the microbial contamination was tested,while the metabolism was analyzed,and the exogenous gene expression was determined. Results The obtained CHO-K1-SFS cell line was suitable for serum-free suspension culture,of which the maximum density reached 3. 8 × 10^6cells / ml when inoculated at an initial density of 3 × 10^5cells / ml,while the mean doubling time was 29. 7 h. No contamination with bacteria,fungi,viruses or mycoplasma was observed. The utilization rate of glucose was high,and a quantity of lactic acid was produced. Exogenous gene was effectively expressed. Conclusion The serum-free suspension culture of CHO-K1-SFS cell line was successfully established,which laid a foundation of high expression of exogenous gene.
出处 《中国生物制品学杂志》 CAS CSCD 2014年第2期180-184,共5页 Chinese Journal of Biologicals
基金 西北民族大学创新项目中央专项(ycx13174)
关键词 CHO-K1细胞 无血清培养 悬浮培养 生物学特性 CHO-K1 cells Serum-free culture Suspension culture Biological characteristics
  • 相关文献

参考文献16

  • 1申烨华,耿信笃.CHO细胞表达系统研究新进展[J].生物工程进展,2000,20(4):23-25. 被引量:41
  • 2Moreira AR. The evolution of protein expression and cell culture[J].{H}Biopharm International-The Applied Technologies Of Biopharmaceutical Develo,2007,(10):56-65.
  • 3Dingermann T. Recombinant therapeutic proteins:production platforms and challenges[J].{H}Biotechnology Journal,2008,(1):90-97.
  • 4Even MS,Sandusky CB,Barnard ND. Serum-free hybridoma culture:ethical,scientific and safety considerations[J].{H}Trends in Biotechnology,2006,(3):105-108.
  • 5Bulter M. Animal cell cultures:recent achievements and perspectives in the production of biopharmaceuticals[J].{H}Applied Microbiology and Biotechnology,2005,(3):283-291.
  • 6Jagschies G. Where is biopharmaceutical manufacturing heading[J].{H}Biopharm International-The Applied Technologies Of Biopharmaceutical Develo,2008,(10):72-88.
  • 7国家药典委员会.中华人民共和国药典(三部)[S]{H}北京:中国医药科技出版社,201016-1792-94.
  • 8Newman C. Serum-free cell culture-the ethical,scientific and economic choice[J].Biomed Scient,2003.941-942.
  • 9Renner WA,Jordan M,Eppenberger HM. Cell-cell adhesion and aggregation:Influence on the growth behavior of CHO cells[J].{H}Biotechnology and Bioengineering,1993,(2):188-193.
  • 10Sinacore MS,Charlebois TS,Harrison S. CHO DUKX cell lineages preadapted to growth in serum-free suspension culture enable rapid development of cell culture processes for the manufacture of recombinant proteins[J].{H}Biotechnology and Bioengineering,1996,(4):518-528.

二级参考文献25

共引文献73

同被引文献10

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部